Navigation Links
Cheryl Fossum Graham Joins Knopp Neurosciences as Head of Regulatory and Development Strategy
Date:10/3/2007

where she earned Phi Beta Kappa Honors.

About KNS-760704

KNS-760704 is an orally administered small molecule in clinical development by Knopp for the treatment of amyotrophic lateral sclerosis (ALS). The drug is an optical enantiomer of a selective, high affinity dopamine agonist marketed in other neurological indications. Both KNS-760704 and the marketed agonist demonstrate neuroprotective properties independent of dopamine receptor activity, but KNS-760704 exhibits greatly reduced dopamine receptor affinity. This makes it possible to clinically evaluate the potential neuroprotective activity of KNS-760704 over a broad dose range.

About ALS

Amyotrophic lateral sclerosis (ALS), often called Lou Gehrig's disease, is a rapid, universally fatal neurodegenerative disorder characterized by progressive muscle weakness and wasting. ALS affects adults in the prime of life and creates a substantial burden for caregivers. U.S. prevalence is nearly 30,000 and the incidence is 1.2 per 100,000. Only a single drug has been approved for the treatment of ALS. Life expectancy after symptom onset is usually three to five years.

About Knopp Neurosciences Inc.

Knopp Neurosciences (http://www.knoppneurosciences.com) is a drug discovery and development company focused on delivering breakthrough treatments for neurological disorders through innovation, experience, and partnership. The company's lead product candidate is KNS-760704, an orally bioavailable small molecule in development for the treatment of ALS. Knopp's leadership includes experienced neuroscience drug development and discovery executives formerly associated with major pharmaceutical companies. Knopp's financing has been led by Saturn Capital Inc. of Boston as placement agent and Saturn Partners II as lead funder.

This press release contains "forward-looking statements," including statements relating to Knopp's planned reg
'/>"/>

SOURCE Knopp Neurosciences Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
2. Rat joins list of cloned animals
3. Richard Gere Joins Indian Stars For Fight Against AIDS
4. Enbrel Joins with Methotrexate to Cure Rheumatoid Arthritis
5. Anoushka Joins Hands With WFP to Feed the Poor
6. India Joins Hands With Global Body for Vaccine Research
7. Another Statewide Organization Joins the Fight Against Assisted Suicide
8. Two-year-old Joins Mensa, Becomes Its Youngest Ever Genius
9. Handbook cum diary on regulatory information
10. Drug regulatory officials giving the nod for sale of Unapproved drug formulations in India
11. Tumor Suppressor p53s Contradictory Regulatory System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)... Check to benefit ALS Therapy Alliance to be pr... Tonight, WOONSOCKET, R.I., July 25 /PRNewswir...it has raised a record-breaking $4.4 million in ju... campaign for ALS research. This is,the seventh ye..., has,raised more than $15 million for ALS researc...
(Date:7/25/2008)... New program delivers imm...nk.html [24-hour telephone access to language int...or seeking multilingual solutions. , ...8 -- -- LLE® http://www.lle-inc.com/index.ht...ding provider of interpretation, translation, and ...
(Date:7/25/2008)... This donation will be us... protective services for children , ...IVCi, LLC ( www.ivci.com ), a leading integrator ...gh definition video conferencing, telepresence, au...ervices, announced today that it has donated video...
(Date:7/24/2008)... WASHINGTON, July 24 /PRNewswire-USNewswire/ --...ment this evening in support of the Tom Lantos,and... Tuberculosis, and,Malaria Reauthorization Act of ... passed the House this evening by a vote of 303 to...re into law., "Today the House took an historic v...
Breaking Medicine News(10 mins):Health News:CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 2Health News:LLE Launches Over-the-Phone Interpretation OPI Easy Switch Program 3Health News:Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 2Health News:Pelosi Statement on House Passage of Global AIDS Legislation 2
...arly Online Publication, released on the 5th of Oc...about chronic diseases, has a comprehensive report... article, co-authored // by Union Health Minister ...ctive public-health response to the growing challe...
...litus is an independent risk factor for cardiovasc...s the risk by 2-6 fold relative to nondiabetic sub.../ mellitus patients will die of an atherosclerotic...nfers increased risk for cardiovascular disease, a...
... between diet and health is well recognized, howev...al relationship between a particular dietary compo...ecial interest // particularly for environmental p...he food chain. In recent years, a number of studie...
...ways been looked at by outsiders as the land of my...armonious central key to getting in touch with the... to // this large sub-continent then what meets th...njoyed without a real time experience. Tourism ha...
Other Medicine News:Health News:Strategies to prevent the rising tide of the epidemic of chronic diseases 2Health News:Athletes Are More Prone To Environmental Pollutants Due To Choice Of Diet 2
(Date:7/24/2008)... July 24 /- Alexza,Pharmace...t it has initiated,its second Phase 3 clinical tri...n inhalation product candidate being developed for... schizophrenia or bipolar disorder.,Alexza believe...okinetic,(PK) properties resulting from inhaled lo...
(Date:7/24/2008)...ewswire-FirstCall/ -- MacroChem Corporation (OTC,B...Phase 2 clinical trial,involving 37 patients who c...efficacy and safety study of EcoNail, a topical an...s (nail fungus). The composite,primary efficacy en...,negative mycology (negative fungal culture and ne...
(Date:7/23/2008)...RNewswire-USNewswire/ -- The following was,release...nyers, Ranking Member Smith, and Members of the Co...today., Since I appeared before this Committee al...uainted with the talented and dedicated profession...ey do, and I have come to,appreciate that much mor...
(Date:7/23/2008)...-Enabling Work with Protein Therapeutics that ...ystem, CAMBRIDGE, Mass., July 23 /- ...nitiated a corporate growth plan with the,appointm...fficer and the,establishment of its headquarters i...Emlen, M.D., a co-founder of the company who remai...
Breaking Medicine Technology:Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 6MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3ESBATechs Antibody Fragments Demonstrate Penetration into the Eye with Topical Delivery via Eye Drops 3464 1ESBATechs Antibody Fragments Demonstrate Penetration into the Eye with Topical Delivery via Eye Drops 3464 2ESBATechs Antibody Fragments Demonstrate Penetration into the Eye with Topical Delivery via Eye Drops 3464 3Protect Your Adolescents Against More Than Just A Cold This Winter 12551 1Protect Your Adolescents Against More Than Just A Cold This Winter 12551 2Public Health Experts Argue for Integrated Services to Avert 7 Million HIV Infections by 2010 12549 1Public Health Experts Argue for Integrated Services to Avert 7 Million HIV Infections by 2010 12549 2Family Friends and Support Groups Add Picture Messaging to Inspire and Motivate Anywhere Anytime 12547 1Family Friends and Support Groups Add Picture Messaging to Inspire and Motivate Anywhere Anytime 12547 2
For Detection of Bile Component in Reflux Disease
The Medtronic G|3 Urodynamic System is designed to make,your job easier, with the intuitive Sensic Navigation,Software and increased hardware functionality and options.
...technology, pathology specimen imaging is now adva... manipulation, analysis, interpretation and telepa... is analogous to the change that occurred in radio... imaging departments and imaging clinics through t...
...phoresis system is designed to optimize and comple...RYS 2 utilizes liquid flow electrophoresis for app...ugh continuous sample feed and the use of eight ve..., a throughput of 90 serum protein results per hou...
Medicine Products: